| 000 | 01766 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250514185924.0 | ||
| 264 | 0 | _c20040520 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1530-440X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchachter, H M | |
| 245 | 0 | 0 |
_aHealth effects of omega-3 fatty acids on asthma. _h[electronic resource] |
| 260 |
_bEvidence report/technology assessment (Summary) _cMar 2004 |
||
| 300 |
_a1-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthma _xdiet therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aControlled Clinical Trials as Topic |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 |
_aFatty Acids, Omega-3 _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aReisman, J | |
| 700 | 1 | _aTran, K | |
| 700 | 1 | _aDales, B | |
| 700 | 1 | _aKourad, K | |
| 700 | 1 | _aBarnes, D | |
| 700 | 1 | _aSampson, M | |
| 700 | 1 | _aMorrison, A | |
| 700 | 1 | _aGaboury, I | |
| 700 | 1 | _aBlackman, J | |
| 773 | 0 |
_tEvidence report/technology assessment (Summary) _gno. 91 _gp. 1-7 |
|
| 999 |
_c14843495 _d14843495 |
||